Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiency

• References

• 1 The Human Gene Mutation Database. (HGMD Available at: http://www.hgmd.cf.ac.uk/ac/gene. php?gene=SERPINC1. Accesed: January 10, 2013.
• 2 Lane DA, Bayston T, Olds RJ. et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
• 3 Martínez-Martínez I, Navarro-Fernández J, Ostergaard A. et al. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. Blood 2012; 120: 900-904.
• 4 Corral J, Hernandez-Espinosa D, Soria JM. et al. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood 2007; 109: 4258-4263.
• 5 Mushunje A, Zhou A, Carrell RW. et al. Heparin-induced substrate behavior of antithrombin Cambridge II. Blood 2003; 102: 4028-4034.
• 6 Sanchez C, Alessi MC, Saut N. et al. Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generation. J Thromb Haemost 2008; 6: 1975-1977.
• 7 Roldán V, Ordoáez A, Marín F. et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost 2009; 101: 483-486.
• 8 Corral J, Huntington JA, González-Conejero R. et al. Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis. J Thromb Haemost 2004; 2: 931-939.
• 9 Martínez-Martínez I, Ordóñez A, Navarro-Fernández J. et al. Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation. Haematologica 2010; 95: 1358-1365.
• 10 Caspers M, Pavlova A, Driesen J. et al. Deficiencies of antithrombin, protein C and protein S - Practical experience in genetic analysis of a large patient cohort. Thromb Haemost 2012; 108: 247-257.
• 11 Luxembourg B, Delev D, Geisen C. et al. Molecular basis of antithrombin deficiency. Thromb Haemost 2011; 105: 635-646.
• 12 Martínez-Martínez I, Navarro-Fernández J, Aguila S. et al. The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency. Mol Med 2012; 18: 762-770.
• 13 Corral J, Vicente V. Inherited thrombophilic conditions. Hematology 2012; 17 (Suppl. 01) 163-166.
• 14 Raja SM, Chhablani N, Swanson R. et al. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis. J Biol Chem 2003; 278: 13688-13695.
• 15 de Haan HG, Bezemer ID, Doggen CJM. et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 2012; 120: 656-663.
• 16 Jobin F, Vu L, Lessard M. Two cases of inherited triple deficiency in a large kindred with thrombotic diathesis and deficiencies of antithrombin III, heparin cofactor II, protein C and protein S. Thromb Haemost 1991; 66: 295-299.
• 17 van Boven HH, Reitsma PH, Rosendaal FR. et al. Factor V Leiden (FVR506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417-421.
• 18 Perry DJ, Daly ME, Colvin BT. et al. Two antithrombin mutations in a compound heterozygote: Met20Thr and Tyr166Cys. Am J Hematol 1995; 50: 215-216.
• 19 Emmerich J, Vidaud D, Alhenc-Gelas M. et al. Three novel mutations of antithrombin inducing high-molecular-mass compounds. Arterioscler Thromb Vasc Biol 1994; 14: 1958-1965.
• 20 Tait RC, Walker ID, Perry DJ. et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-112.